Impact of Guideline-Directed Medical Therapy on 2-Year Mortality in Japanese Patients Undergoing Endovascular Therapy for Femoropopliteal Lesions ― Results of the Multicenter GEMINI-FP Study ―
Circulation Journal · 2025
DOI: 10.1253/circj.cj-25-0086 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation Journal, 2025. Verfasst von Tatsuro Takei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tenyoukai Central Hospital. Hauptthemen laut MEDLINE: Endovascular Procedures, Femoral Artery, Popliteal Artery, Peripheral Arterial Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The effect of guideline-directed medical therapy (GDMT) on mid-term mortality in Asian patients, including Japanese patients, who have undergone endovascular therapy (EVT) for lower extremity artery disease remains still unclear. This study evaluated the effects of GDMT, defined as the combined prescription of antiplatelet agents, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, on 2-year mortality in Japanese patients undergoing EVT for femoropopliteal (FP) lesions. METHODS AND RESULTS: In this multicenter retrospective study, 1,756 registered patients were divided into 2 groups: those who received all 3 medications that comprised GDMT (full GDMT group) and those who received ≤2 medications (non-GDMT group). After propensity score matching, the baseline characteristics did not differ significantly between the 413 pairs of participants in the full GDMT and non-GDMT groups. All-cause mortality within 2 years was significantly lower in the full GDMT than non-GDMT group (14.3% vs. 20.8%; log-rank P=0.030). Mortalities from cardiovascular and cardiocerebrovascular diseases within 2 years were also significantly lower in the GDMT group (4.2% vs. 9.5% [log-rank P=0.021] and 4.2% vs. 10.5% [log-rank P=0.007], respectively). CONCLUSIONS: In Japanese patients undergoing EVT for FP lesions, GDMT may improve all-cause, cardiovascular, and cardiocerebrovascular mortality within 2 years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Tenyoukai Central Hospital.
- Department of Cardiology, Nagoya Heart Center.
- Department of Cardiology, Ogaki Municipal Hospital.
- Department of Cardiology, Miyazaki Medical Association Hospital.
- Department of Cardiology, Sendai Kousei Hospital.
- Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center.
Zitieren
APA
Takei, T., Tokuda, T., Yoshioka, N., Ogata, K., Tanaka, A., Kojima, S., Yamaguchi, K., Yanagiuchi, T., Nakama, T., & LEADers PAD Investigators (2025). Impact of Guideline-Directed Medical Therapy on 2-Year Mortality in Japanese Patients Undergoing Endovascular Therapy for Femoropopliteal Lesions ― Results of the Multicenter GEMINI-FP Study ―. Circulation Journal. https://doi.org/10.1253/circj.cj-25-0086
Vancouver
Takei T, Tokuda T, Yoshioka N, Ogata K, Tanaka A, Kojima S, et al. Impact of Guideline-Directed Medical Therapy on 2-Year Mortality in Japanese Patients Undergoing Endovascular Therapy for Femoropopliteal Lesions ― Results of the Multicenter GEMINI-FP Study ―. Circulation Journal. 2025. doi:10.1253/circj.cj-25-0086
BibTeX
@article{Takei2025,
author = {Takei, Tatsuro and Tokuda, Takahiro and Yoshioka, Naoki and Ogata, Kenji and Tanaka, Akiko and Kojima, Shunsuke and Yamaguchi, Kohei and Yanagiuchi, Takashi and Nakama, Tatsuya and LEADers PAD Investigators, LEADers PAD Investigators},
title = {Impact of Guideline-Directed Medical Therapy on 2-Year Mortality in Japanese Patients Undergoing Endovascular Therapy for Femoropopliteal Lesions ― Results of the Multicenter GEMINI-FP Study ―},
journal = {Circulation Journal},
year = {2025},
doi = {10.1253/circj.cj-25-0086}
}
EUVIMED